Expression Genetics, Inc.
7Patents
0Active
7Granted
31Portfolio score
Filing activity: May 20, 1999 → May 21, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6696038B1 | Cationic lipopolymer as biocompatible gene delivery agent | Human Necessities | 147 | Expired |
| US6652886B2 | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents | Emerging Cross-Sectional Technologies | 134 | Expired |
| US6586524B2 | Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier | Human Necessities | 126 | Expired |
| US6217912A | Polyester analogue of poly-L-lysine as a soluble, biodegradable gene delivery carrier | Chemistry; Metallurgy | 92 | Expired |
| US6177274A | Hepatocyte targeting polyethylene glyco-grafted poly-L-lysine polymeric gene carrier | Human Necessities | 84 | Expired |
| US6517869B1 | Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake | Emerging Cross-Sectional Technologies | 59 | Expired |
| US7374930B2 | GLP-1 gene delivery for the treatment of type 2 diabetes | Human Necessities | 57 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.